May/June 2010

 

Issue

Supplement

 

EDITOR’S PAGE: Advances in Drug Delivery

By Robert L. Avery, MD, Associate Medical Editor, Allen C. Ho, MD, Chief Medical Editor

NEWS FEATURE

The Potential Role of Regenerative Medicine in Ophthalmology

Pfizer is investing resources and scientific know-how to develop stem-cell therapies for retinal diseases.

By Jennifer Kreatsoulas, PHD, Senior Associate Editor

BUSINESS OF RETINA

FELLOWS’ FOCUS: Tips for the New Retina Attending

By Darrell E. Baskin, MD; Chirag P. Shah, MD, MPH; and Jeremy D. Wolfe, MD

RETINA IN THE ASC: Efficiency in the ASC: A Team Effort

At Spectra Eye Institute, we strive toward the common goal of excellent patient care.

By Jan Amator, MBA

RETINA SURGERY

GLOBAL PERSPECTIVES: German Organization Advocates for Ophthalmic Surgeons' Interests

The BDOC, an ophthalmic professional organization in Germany, negotiates contracts with health insurance companies and advocates for governmental policies that affect its members.

With Armin Scharrer, MD

RETINA PEARLS: Incision-related Complications of Sutureless Vitrectomy

Rare complications of vitrectomy with small-gauge instrumentation can significantly affect vision.

By Susanne Binder, MD

SURGICAL UPDATES: Pars Plana Vitrectomy and Lensectomy with a 23-gauge Vitrectomy System

By Aziz A. Khanifar, MD; Harry K. Roux, MD; and R.V. Paul Chan, MD

ONCOLOGY

CASE REPORTS IN OCULAR ONCOLOGY: Uveal Coloboma: The Related Syndromes

By Irina Belinsky, MD; Aparna Ramasubramanian, MD; Neelema Sinha, MD; and Carol Shields, MD

COVER STORIES

Sustained- release Corticosteroid Delivery Systems

Implant technology offers promising solutions to the burden of repeated injections for retinal diseases.

By Szilard Kiss, MD

Topical Drug Delivery for Posterior Segment Disease

Novel formulations offer possibilities for efficacious therapies through topical routes.

By Daniel F. Kiernan, MD; and Jennifer I. Lim, MD

Update on Endophthalmitis After Anti-VEGF Injection

Standardized preparation may be a factor in low infection rate.

By Andrew A. Moshfeghi, MD, MBA

A New Target for Neovascular AMD

This molecule might enable earlier detection of neovascularization.

By Jayakrishna Ambati, MD

Sustained Drug-delivery for Retinal Disease

Current technologies include implanted and injected devices.

By Glenn J. Jaffe, MD

ONCOLOGY FEATURE

Von Hippel-Lindau Disease

A review of the physiopathlology, epidemiology, diagnosis, and treatment for this rare condition.

By Hadas Newman, MD; and Paul T. Finger, MD

MEDICAL RETINA FEATURE

Combination Therapy for RVO

The complexity of this multifactorial disease state suggests a need for a tailored treatment approach.

By Seenu M. Hariprasad, MD; Veeral Sheth, MD; and Paulpoj Chiranand, MD

RETINAL IMAGING FEATURE

Imaging and Pharmacologic Approaches in the Treatment of Geographic Atrophy in AMD

Imaging with FAF offers new insight into how and why GA progresses in some patients.

By Frank G. Holz, MD

5 Questions with Peter K. Kaiser, MD

Dr. Kaiser is a Professor of Ophthalmology at the Cleveland Clinic Lerner College of Medicine and a staff surgeon in the Vitreoretinal Department at the Cole Eye Institute, Cleveland Clinic. He is the Founding Director of the Digital Optical Coherence Tomography Reading Center (DOCTR) at the Cole Eye Institute.

 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Scott Krzywonos
Editor-in-Chief
484-581-1880
skrzywonos@bmctoday.com

Janet Burk
Publisher
214-394-3551
jburk@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.